This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of novel drug candidates. Its structure, featuring a cyclopropane ring and a fluorophenyl group, makes it a valuable intermediate in the creation of molecules targeting neurological and psychiatric disorders. It has shown potential in the design of compounds that interact with specific receptors in the brain, such as serotonin or dopamine receptors, which are critical in treating conditions like depression, anxiety, and schizophrenia. Additionally, its fluorinated aromatic ring enhances metabolic stability and bioavailability, making it a useful component in optimizing drug efficacy and pharmacokinetics. Researchers also explore its applications in medicinal chemistry for developing enzyme inhibitors or modulators of biological pathways.